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Summary
Rhmod syndrome is a rare genetic disorder thought to
result from mutations at a “modifier” but not at the
suppressor underlying the regulator type of Rhnull dis-
ease. We studied this disorder in a Jewish family with a
consanguineous background and analyzed RH and
RHAG, the two loci that control Rh-antigen expression
and Rh-complex assembly. Despite the presence of a d
(D-negative) haplotype, no other gross alteration was
found at RH, and cDNA sequencing showed a normal
structure for D, Ce, and ce Rh transcripts in family mem-
bers. However, analysis of RHAG transcript, which en-
codes Rh50 glycoprotein, identified a single GrT trans-
version in the initiation codon, causing a missense amino
acid change (ATG[Met]rATT[Ile]). This point mutation
also occurred in the genomic region spanning exon 1 of
RHAG, and its genotypic status in the mother and two
children was confirmed by analysis of single-strand
conformation polymorphism. Although blood typing
showed a very weak expression of Rh antigens, immu-
noblotting barely detected the Rh proteins in the Rhmod
membrane. In vitro transcription–coupled translation
assays showed that the initiator mutants of Rhmod—but
not those of the wild type—could be translated from
ATG codons downstream. Our findings point to incom-
plete penetrance of the Rhmod mutation, in the form of
“leaky” translation, leading to some posttranslational
defects affecting the structure, interaction, and pro-
cessing of Rh50 glycoprotein.
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Introduction
Rh (rhesus) deficiency syndrome is manifest as Rhnull or
Rhmod, a rare genetic disorder of the red blood cells
(RBCs) that is characterized by an altered expression of
Rh antigens as phenotypic markers. Whereas Rhnull cells
lack all Rh antigens (Vos et al. 1961), Rhmod cells display
a markedly reduced antigen expression (Chown et al.
1972). Clinically, Rh-deficient individuals exhibit a mild
to moderate chronic hemolytic anemia accompanied by
a varying degree of spherostomatocytosis (Nash and
Shojania 1987). In addition, Rh-deficient RBCs show
biochemical and physiological changes in the plasma
membrane, including an increased cation permeability,
elevated ATPase activity, altered lipid organization, and
absent or diminished expression of multiple Rh-related
integral membrane proteins (reviewed in Agre and Car-
tron 1991b).
Classic genetic studies have established that Rh-defi-
ciency syndrome is transmitted in an autosomal recessive
fashion most often associated with consanguinity. De-
pending on the origin of underlying mutations, Rhnull is
divided into the amorph and regulator types: the former
arises by mutations inactivating the antigen locus RH
itself, whereas the latter results from mutations at a
separate suppressor modulating Rh-antigen expression
(Race and Sanger 1975). These genetic postulates are
now confirmed by the identification, in unrelated Rhnull
cases, of different mutations inRH versusRHAG,which
encode Rh30 polypeptides and Rh50 glycoprotein, re-
spectively (Cherif-Zahar et al. 1996, 1998; Huang 1998;
Huang et al. 1998a, 1998b;Hyland et al. 1998; Kawano
et al. 1998). Such molecular analyses provide direct ev-
idence proving that both the RH locus and the RHAG
locus are essential for the expression and function of the
Rh structures as a multisubunit complex in the RBC
plasma membrane.
Although most Rhnull cases have been attributed to a
defective “regulator,” Rhmod was first thought to result
from some mutations that might have involved a second,
different “modifier” gene (Chown et al. 1972; McGuire
Mallory et al. 1976). This hypothesis was based mainly
on the observation that Rhmod cases exhibit a variable
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antigen expression acted on by their RH-genotype com-
positions. However, the phenotypic diversity may also
reflect differences in the degree of penetrance of muta-
tions in the same suppressor that causes the regulator
type of Rhnull disease. The characterization of the ge-
nomic organization of RHAG enabled us to devise a
mutation-screening procedure to test this hypothesis
(Huang 1998; Huang et al. 1998b). We investigated a
Jewish family of Russian origin in which the Rhmod phe-
notype is transmitted on a consanguineous background.
We describe here a rare mutation in the initiator ATG
of RHAG and show in vitro that downstream ATGs of
the mutated Rh50 can be utilized for alternative trans-
lation initiation. Our findings correlate the “leaky” ex-
pression of Rhmod with incomplete penetrance of a mu-
tation in the RHAG suppressor but not with a mutation
in the proposed “modifier” gene.
Subjects, Material, and Methods
Blood Samples and Hemagglutination Test
Blood samples under study were obtained from four
members of the Rhmod family: SM (the homozygote of a
consanguineous pedigree), her husband, and her two ob-
ligate-heterozygous children. SM’s husband was from an
unrelated family known not to be consanguineous. RBC
hemagglutination in test tubes was performed according
to standard methods. Blood samples used as controls
were drawn from D-positive (D) and D-negative (D)
human blood donors with the DCe/DCe and dce/dce
genotypes, respectively.
Genomic Southern Blot Analysis
Genomic DNA was isolated from leukocyte pellets.
The Rh50 probe was a full-length cDNA (nucleotides
13 to 1256) isolated from a placenta cDNA library
(Huang 1998). The Rh30 cDNA probes are region spe-
cific and span, respectively, the 5′ (exons 1–3, nucleotides
1 to 480), middle (exons 4–7, nucleotides 515 to 1073),
and 3′ portions (exons 8–10 plus the 3′ UTR, nucleotides
1074 to 1456) (Huang 1996). Genomic DNA was di-
gested with restriction enzyme SphI, and blots were hy-
bridized with 32P-labeled cDNA probes.
Reverse Transcriptase–PCR (RT-PCR)
Erythroid total RNA was isolated as described else-
where (Goossens and Kan 1981) and was extracted with
the Trizol reagent (Bethesda Research Laboratories
[BRL]). Rh30 and Rh50 transcripts were analyzed by
gene-specific RT-PCR, as described elsewhere (Huang
1996, 1998). Primers for cDNA synthesis and PCR am-
plification are listed in table 1. The Rh30 or Rh50
mRNA was converted into cDNA by means of either
a gene-specific 3′ UTR primer or an adaptor-linked
oligo(dT)16 primer (Frohman et al. 1988) (table 1). The
cDNA was then amplified by two pairs of specific prim-
ers spanning the entire coding sequence for the Rh30 or
Rh50 protein.
Rapid Amplification of cDNA 5′ Ends (5′ RACE) and
Subcloning
To determine whether the transcription start site is
affected, the 5′ end of Rh50 cDNAs was mapped by
means of the 5′ RACE System Version 2.0 kit (BRL).
Approximately 2 mg of total RNA was reverse-tran-
scribed by primer Ex-3a (table 1). The single-stranded
cDNAwas dC-tailed and then was amplified by adaptor-
linked poly(dG) and primer Ex-2a. The cDNA products
from the control and SM were purified and ligated to
the pCR2.1 TA vector (Invitrogen), and positive
clones were identified by X-Gal selection and PCR
amplification.
Amplification and Analysis of Genomic Sequences
To verify the mutation identified by cDNA analysis,
the RHAG sequences were amplified by means of total
genomic DNA used as a template. On the basis of the
structural organization of RHAG (Huang 1998), gene-
specific primers were designed to amplify the 5′ pro-
moter, the exon 1–spanning region, and the exon/intron
junctions. The amplified products were purified and ei-
ther were sequenced or were analyzed by single-strand
conformation polymorphism (SSCP), as described else-
where (Huang et al. 1998b).
Immunoblot Analysis of RBC Membrane Proteins
Isolation of RBC membrane proteins and their im-
munoblot analysis were performed as described else-
where (Towbin et al. 1979; Huang et al. 1998a). The
two available monoclonal antibodies (mAbs) were used:
2D10, for Rh50 (Mallinson et al. 1990), and LOR-
15C9, for Rh30(D) (Apoil et al. 1997). For band visu-
alization, peroxidase-conjugated anti–mouse Ig and
anti–human Ig were used as the second antibodies for
2D10 and LOR-15C9, respectively.
DNA Sequencing
Unless described otherwise, the amplified cDNA and
genomic products were sequenced directly after sepa-
ration by native 5% PAGE. For subcloned inserts of 5′
RACE and in vitro–translation constructs, multiple
clones were sequenced on a 373A automated DNA se-
quencer using fluorescent-dye tags as chain terminators
(Applied Biosystems).
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Table 1
Synthetic Oligonucleotides for Analysis of the Rh50 Glycoprotein Gene
Categorya Sequence
Nucleotide
Positionb Location
I. cDNA PCR:
3′-UTRa 5′-AATGGGAAAGGAAGCTGGAGAGCA-3′ 1321 to 1298 3′-UTR
Ex-1s 5′-AGTGTGCCTCTGTCCTTTGCCACA-3′ 27 to 4 5′-UTR
Ex-4s 5′-GAAGAGTCCGCATACTACTCAGAC-3′ 601 to 624 Exon 4
Ex-5a 5′-CTGTTTGTCTCCAGGTTCAGCAAT-3′ 708 to 685 Exon 5
Ex-10a 5′-CCATGTCCATGGAACTGATTGTCA-3′ 1256 to 1233 Exon 10
(dT)16 anchor 5
′-GTCATGACTCGAGTCGACATCGA(T)16-3
′
II. 5′ RACE:
Ex-3a 5′-ATTGTCATGATCAGCATTTGGGTG-3′ 437 to 414 Exon 3
Ex-2a 5′-CCAAAGCAGCAACGATGAGGTTG-3′ 268 to 246 Exon 2
III. SSCP:
5′P-1s 5′-CATGCAGTCAAATTCCACACACAG-3′ 97 to 74 5′ Region
Ex-1a 5′-CTCAAAGAATATGCCCATGTCTG-3′ 147 to 125 Exon 1
IV. Genomic PCR:
5′P-2s 5′-TCCAGCTTTGCTTGACTGATTGCC-3′ 679 to 656 5′ Region
In-1a 5′-CAAAGAGCTCAAGGGTTTATAGTA-3′ 95 to 72 Intron 1
V. Construction of in vitro–translation plasmids:c
Ex-1s 5′-AGTGTGCCTCTGTCCTTTCCCACA-3′ 27 to 4 5′-UTR
Ex2-Sa 5′-TTATTTCTTCAGGAAGGTCATGAG-3′ 222 to 202 Exon 2
Ex3-La 5′-CTATTATTCACTAACCAGGTATTC-3′ 483 to 466 Exon 3
NOTE.—For brevity, Rh30 primers have not been listed (see Huang 1996), since no abnormality was found at RH.
a Sense (denoted by an “s” suffix) and antisense (denoted by an “a” suffix) primers to 5′ or 3′ UTR; exons (as “Ex”), 5′ regions (denoted as
“P”), and introns (denoted as “In”) are indicated.
b Positions of exon primers are counted from the first base of initiation codon ATG, whereas the intron primer is designated on the basis of
its distance from the adjacent exon.
c Introduced termination codons are underlined. Ex2-Sa was used for the construction of WT-S and Rhmod-S pairs, and Ex3-La was used for
the construction of WT-L and Rhmod-L pairs.
In Vitro Transcription–Coupled Translation Analysis
To evaluate the effect of the initiator mutation, two
shortened forms of RHAG cDNA from SM and her
husband (the control) were constructed and tested by in
vitro transcription–coupled translation. This was nec-
essary because a size difference of seven amino acids
cannot be detected if the full-length forms are used in
protein translation. The subcloned cDNAs were used as
amplicons for PCRwith gene-specific primers containing
introduced stop codons (table 1). The products were
purified by PAGE and were subcloned into the pRc/
CMV vector with a T7 promoter (Invitrogen). The ori-
entation, open reading frame, and change in ATG ini-
tiation codon of the wild-type and Rhmod constructs were
verified by sequencing. The plasmids were linearized
with BstXI, and transcription-coupled translation assays
were performed according to the supplier’s specifications
(Promega). 35S-methionine (NEN Life Science Products)
was used as a label, and the translated products were
analyzed by SDS-PAGE followed by autoradiography.
Results
Family Data and RBC Hemagglutination
SM and her brother SS (deceased) were first described
as Rhnull siblings of a consanguineous Jewish pedigree of
Russian origin. Their parents were typed as D but
produced three D children. By 1984, SM had a well-
compensated hemolytic anemia, whereas SS had a nor-
mal hematological count with numerous spherocytes
and stomatocytes after splenectomy.
The results of RBC direct tests were as follows:
SM, DCEce; her husband, DCEce;
her son, DCEce; and her daughter,
DCEce. Further tests on SM, with eight anti-
e, four anti-Rh17, and one anti-Rh29, were all negative;
however, when her cells were treated with papain and
were tested directly, they reacted weakly with one poly-
clonal anti-e and reacted moderately with four mono-
clonal anti-e (MS-17, -21, -62, and -69), all anti-Rh17,
and anti-Rh29.When tested either by saline-RT and spin
(SRS) or by indirect antiglobulin test (IAT), the untreated
cells were nonreactive to three anti-D (LOR-15C9,
DB176A, and DM75-2). Although nonreactive by SRS,
the untreated cells were agglutinated strongly in IAT, by
the fourth anti-D (ND04001). These results show that
SM is a genuine case of Rhmod disease, rather than a case
of Rhnull disease.
Southern Blot Analysis of RH and RHAG
Figure 1 shows the Southern blots for the Rhmod family.
In the RH polymorphic region (Huang et al. 1996), a
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Figure 1 Southern blot analysis of RH and RHAG loci in the
Rhmod family. Genomic DNAs were digested with restriction enzyme
SphI, and the blots were hybridized with the Rh30 (left panel) and
Rh50 (right panel) cDNA probes. The gene origin and exon content
of various SphI bands assigned to the polymorphic region of RH
(Huang et al. 1996) are denoted. Note the reduction of intensity in
RHD-specific 8.9- and 1.2-kb bands and the presence of a ce-specific
band in all members except the son. The blot probed with full-length
Rh50 cDNA showed no significant difference between controls and
Rhmod family members. Size markers (in kb) ofHindIII-cleaved lambda-
phage DNA are shown to the left of the gel panels.
reduced dosage in the D-specific 8.9- and 1.2-kb bands,
indicative of a d (D) haplotype on one chromosome,
was evident in SM, her husband, and her daughter (fig.
1, left). The three also showed a reduced intensity in the
Ce-specific 5.4- and 1.9-kb bands but had a ce-specific
7.3-kb band. The banding pattern in the son was ap-
parently identical to that in D individuals of the DCe/
DCe genotype. The data indicated the transmission of
two haplotypes DCe and dce in the family. Analysis of
RHAG showed no gross alteration, despite the possible
occurrence of some polymorphisms in noncoding
regions (fig. 1, right).
RT-PCR Analysis of RhD and RhCE Transcripts
To exclude mutation at RH, the structure of Rh tran-
scripts was characterized by RT-PCR and sequencing. In
SM, her husband, and her daughter, three types of cDNA
were identified, which were found to encode the D, Ce,
and ce Rh polypeptides, respectively. In the son, only D
and Ce transcripts were identified. The entire sequence
of three cDNAs from SM was obtained but showed no
difference from that of normal subjects. The combined
data of genomic and cDNA analyses allowed for the
exclusion of mutation at the RH locus, as well as for
the inference of gene linkage and segregation in all family
members (fig. 2).
RT-PCR Analysis of RHAG Transcripts
Next we analyzed the Rh50 transcript expressed in
SM’s erythroid cells. No shortened cDNA species indic-
ative of aberrant RNA splicing were detected (gels not
shown). Sequencing of the entire cDNA identified a sin-
gle GrT transversion in the 3 position of the ATG
codon for translation initiation (ATG[Met1]rATT[Ile]).
Since there is a potential ATG triplet (nucleotides 96
to 94) located farther upstream (Huang 1998), 5′
RACE was performed to map the 5′ end of Rh50 tran-
scripts. Sequencing of multiple clones revealed that no
inserts had a sequence beyond 75, demonstrating that
the upstream ATG does not occur in mature mRNAs.
In SM and her husband, the same27A was determined
as the major transcription start site, consistent with the
assignment reported by others (Iwamoto et al. 1998).
These results indicate that the initiator mutation does
not affect RHAG transcription or splicing.
Genomic Analysis of the 5′ Region of RHAG in the
Rhmod Family
To confirm the identified mutation and to determine
its genotype status in family members, the 5′ region of
RHAG, encompassing the promoter, exon 1, and a part
of intron 1, was amplified and sequenced. As shown, a
single peak—for nucleotide 3T in SM and for nucleotide
3G in her husband—was present in the parents, whereas
the same position displayed a composite of T/G in their
children (fig. 3A). This indicated both homozygosity of
the mutation in SM and heterozygosity of the mutation
in the children. The genotype status was further dem-
onstrated by SSCP analysis of the genomic fragments
containing exon 1 (fig. 3B). In addition, no difference
was found in the promoter region and exon/intron junc-
tions (data not shown), compared with the wild-type
RHAG sequences (Huang 1998).
Immunoblot Analysis of Rh30 and Rh50 Proteins
To determine the expression of RhD and Rh50,
gels loaded with equal amounts of RBC membranes
were blotted and subjected to mAb probings. On the
anti-RhD immunoblot, bands of expected molecular
weight—that is, 30–32 kD—were seen in D and in
three family members but not in either SM or D sub-
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Figure 2 Inheritance and linkage of RH in the Rhmod family. Genotypes of four members were determined on the basis of the combined
data from SphI RFLPs (fig. 1) and sequences of the corresponding transcripts. Rh-antigen phenotypes are shown below each family member:
a plus sign () denotes that the individual is positive; a minus sign () denotes that the individual is negative. The Ce or ce gene (unblackened
boxes) is placed upstream of the D gene (blackened boxes) (Carritt et al. 1997). “d” denotes a deletion of the D gene (horizontal line). The
Rhmod proband (i.e., SM) and her husband are genotypically identical at RH, in that they both carry the DCe and dce haplotypes. The random
assortment of the two haplotypes resulted in DCe/DCe and DCe/dce children.
jects (fig. 4A). On the immunoblot visualized by anti-
Rh50 at a dilution of 1:100, a broad diffuse band in the
range of 36–50 kD was seen in all individuals except
SM (fig. 4B). These data suggested an apparent absence
of RhD and Rh50 in the Rhmod membrane. However,
faint bands were visible when the blot overloaded with
Rhmod membrane ghosts was probed with undiluted
2D10 (gel not shown). This observation is consistent
with the results of blood typing, demonstrating a severe
deficiency but not a total abolishment of Rh-protein
expression.
Effect of the Initiator Mutation on In Vitro Translation
The mutational effect was analyzed by in vitro tran-
scription–coupled translation of two pairs of truncated
constructs, made from the wild-type cDNA and from
SM’s cDNA, which differed only in the third position
of the initiation codon—with the wild-type cDNA hav-
ing G and SM’s cDNA having T. The RHAG sequence
was placed under the control of the T7 promoter for
RNA transcription; it starts from nucleotide 27A and
terminates at the indicated codon position in the two
pairs of constructs (fig. 5A).
As shown, in vitro–translation products derived from
the wild-type and Rhmod constructs were readily detect-
able (fig. 5B). The paired longer constructs, WT-L and
Rhmod-L, showed no apparent difference (fig. 5B, left),
since their expected sizes (161 amino acids vs. either 154
or 146 amino acids) were still too close to be differen-
tiated. Nevertheless, the comparable intensity of the
band seen in Rhmod showed an efficient translation in the
absence of the cognate initiation signal. Moreover, the
difference in size and banding pattern became evident
when the paired shorter constructs, WT-S and Rhmod-S,
were used for translation (fig. 5B, right). WT-S gave rise
to a single band, expected of a 74-amino-acid product,
whereas Rhmod-S yielded two different polypeptides, of
smaller size. The two smaller ones were most likely in-
itiated from Met8 and Met16 (fig. 5C), containing 67 and
59 amino acids, respectively. This is because any trans-
lated products starting from Met44 would be !3.5 kD.
Thus, in the presence of a wild-type initiation signal, the
usage of internal ATGs for alternative translation was
avoided; by contrast, the absence of the cognate initiator
resulted in a preferential selection of the immediately
adjacent ATGs. The latter case likely reflects effects of
both the position and context of the cryptic translation
initiation–signal sequences (fig. 5C). Taken together, the
results correlated the Rhmod phenotype with the occur-
rence of alternative translation leading to some post-
translational defects (fig. 6).
Discussion
We have described molecular studies of a Jewish fam-
ily in which Rhmod occurs as an autosomal recessive char-
Huang et al.: Leaky Translation and Rhmod Syndrome 113
Figure 3 Amplification and analysis of the initiator mutation in the Rhmod family. A, DNA sequence profiles spanning the genomic region
relevant to translation initiation. The genomic sequences encompassing exon 1 were amplified by primers 5P-1 and In-1a (see table 1) and then
were directly sequenced. The nucleotide in the 3 position of initiation codon ATG is indicated by a downward-pointing arrow. The husband
shows a normal sequence, whereas the Rhmod proband (i.e., SM) and her children are homozygous and heterozygous for the GrT transversion,
respectively. B, SSCP analysis. The genomic products used for SSCP analysis were amplified by primers 5P-2 and Ex-1a. They were denatured
by heating, were separated on an 8% polyacrylamide gel, and then were stained with silver nitrate. The normal and abnormal bands are denoted
by arrows to the left and right of the gel panels, respectively. The results readily demonstrate the homozygosity and heterozygosity for the point
mutation.
acter on a consanguineous background. To determine
the nature and type of the underlying defect, we inves-
tigated RH and RHAG, whose products are essential
both for the assembly of Rh structures and for the in-
tegrity of RBC membranes (Anstee and Tanner 1993;
Cartron and Agre 1995). Analysis of Rh transcripts pro-
vided results consistent with the pattern of antigen ex-
pression, excluding mutation in the RH-antigen locus
itself. Screening for mutation of RHAG led to the iden-
tification of a single GrT transversion in the ATG codon
for translation initiation of Rh50 in the Rhmod erythroid
cells. To our knowledge, this is the first example of poly-
topic transmembrane (TM) proteins known to be de-
fective in translation initiation in association with a ge-
netic disorder. Other initiator mutations have been
shown to target the genes encoding erythrocyte intra-
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Figure 4 Immunoblot analysis of Rh30 polypeptides and Rh50
glycoprotein in the RBCmembrane. Equal amounts ofRBC-membrane
ghosts from controls and Rhmod family members were loaded and sep-
arated by PAGE under nonreducing conditions. A, Immunoblots
probed with the monoclonal antibody 2D10 against Rh50. A broad
diffuse band in the range of 36–50 kD is detectable in normal and
Rhmod heterozygotes but is barely seen in the Rhmod homozygote (i.e.,
SM). B, Immunoblots probed with LOR-15C9, amonoclonal antibody
specific for the RhD polypeptide only. A band of 30–32 kD is seen in
all D individuals but not in either the D control or the Rhmod
homozygote. Thus, the RhD protein was severely deficient, although
the RhD gene was structurally normal and actively transcribed in
Rhmod.
cellular proteins—that is, globins in thalassemias (Baysal
and Carver 1995), as well as protein 4.1 and b-spectrin
in hereditary spherocytosis (Venizia et al. 1992; Basseres
et al. 1998).
Although their amino acid sequence is only 36% iden-
tical, Rh30 and Rh50 share a quite similar 12-TM to-
pology, serving as the antigen carrier and coexpressor,
respectively (Avent et al. 1990; Cherif-Zahar et al. 1990;
Le Van Kim et al. 1992; Ridgwell et al. 1992; Arce et
al. 1993). They are thought to form a structural core,
providing contact sites to promote the assembly of a
multisubunit complex that may include several other
membrane glycoproteins—for example, LW, CD47, and
GPB (Agre and Cartron 1991a). Such a hypothesis had
been highlighted by the rare occurrence of Rhnull disease
and has now been substantiated by the findings made
in more-recent biochemical and molecular-genetic
studies.
It appears that there is a direct interaction between
the Rh30 and Rh50 proteins, involving their N-terminal
domains (Eyers et al. 1994). Furthermore, LW, CD47,
and GPB are dispensable with regard to the assembly of
Rh structures, since their null status did not affect either
Rh-antigen expression or RBC shape and physiology
(Hermand et al. 1996; Lindberg et al. 1996; Huang
1997). Most notably, both amorph and regulator mu-
tations causing Rhnull disease have been identified
(Cherif-Zahar et al. 1996, 1998; Huang 1998; Huang
et al. 1998a, 1998b; Hyland et al. 1998; Kawano et al.
1998). The mutational spectrum not only confirms an
essential role for RH and RHAG but also indicates the
presence of additional interaction sites in the C-terminal
domains of the two proteins. The reported defects in-
clude two missense changes, but the remaining changes
are either small exonic deletions or splice-site mutations
resulting in frameshift and premature termination. The
abnormal translation initiator shown here specifies a
new molecular basis, thus giving novel insight into the
phenotypic diversity of Rh-deficiency syndrome.
As shown, the GrT mutation did not alter RHAG
expression at the level of transcription or splicing but
led to alternative translation initiation. This initiation
was apparently confined to the two ATGs immediately
adjacent to the wild-type one, despite the fact that mul-
tiple ATGs are present farther downstream (Ridgwell et
al. 1992). Alignment of the sequences flanking the first
four in-frame ATGs of RHAG (fig. 5C) reveals that they
each share a significant homology with the Kozak (1987)
consensus. The cognate ATG(Met1) initiation site con-
tains nine identical nucleotides and has been shown to
be most optimal, since its corresponding constructs did
not give rise to aberrant products. The other three ATGs
have seven or eight nucleotides identical to the consensus
sequence, with the ATG(Met8) and ATG(Met16) cryptic
signals being preferentially selected for translation ini-
tiation in Rhmod. This selection is unlikely, because of an
alteration in binding of the 40S ribosomal subunits to
the cap site of Rh50 mRNA, since the Rhmod transcripts
were shown to have the same 5′ end as was seen in the
wild type. Rather, our data suggest an adjustment in the
mode for the ribosomes to scan mRNA and to find an
AUG suitable to initiate translation, for the strength of
AUG is set mainly by its sequence context and relative
position with respect to the cap site (Iida and Masuda
1996).
The “leaky” translation, although observed in vitro,
provides a direct link to the reduced antigen expression
in Rhmod, suggesting that some posttranslational defects
may have affected the structure, interaction, and pro-
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Figure 5 In vitro transcription–coupled translation assays of the wild-type and Rhmod Rh50 constructs. A, Diagrams of the two pairs of
Rh50 constructs cloned into the pRc/CMV2 vector. The four constructs all start from 27A and are placed downstream of the T7 promoter.
The sizes (in bp) of their coding sequences, from ATG (denoted by blackened diamonds []) to the last codon, is given, and the predicted
length of their polypeptides is bracketed. “WT-L” and “WT-S” denote long and short wild-type constructs, respectively; “Rhmod-L” and
“Rhmod-S” denote long and short mutant constructs, respectively. B, Analysis of in vitro–translation products. In each panel, equal amounts of
linearized control and Rhmod plasmids were used. The apparent molecular size (in kD) of each band is given. Left, 15% SDS-PAGE of [
35S]-
Met–labeled products translated from the paired long constructs. Right, 20% SDS-PAGE of [35S]-Met–labeled products translated from the
paired short constructs. Note the presence of a single band in WT-S and of two smaller bands in Rhmod-S. The dark band at the bottom is due
to free [35S]-Met. C, Alignment of Kozak consensus (top) with the first four in-frame ATGs (boldface), at positions 1, 8, 16, and 44, and their
flanking sequences in RHAG. The sequences surrounding ATG codons farther downstream, at positions 60 and 69, are not shown.
cessing of Rh50 glycoprotein (fig. 6). The use of
ATG(Met8) for translation initiation is expected to pro-
duce a shortened polypeptide lacking seven amino acids,
thereby eliminating the cytoplasmicN-terminal segment.
Nevertheless, the predicted first-TM1 a-helix (Ridgwell
et al. 1992) would be affected only slightly. This is in
contrast with the initiation from ATG(Met16), which
would basically destroy the TM 1 segment, introducing
more-dramatic changes into the mutant protein. With
these N-terminal truncations, the proteins might de-
crease their insertion into the lipid bilayer (Singer 1990),
impair their interaction with Rh30 proteins (Eyers et al.
1994), and become either defective in intracellular trans-
port or susceptible to proteolytic degradation (Cheng et
al. 1990; Deen et al. 1995). Such possible posttransla-
tional events, either alone or in combination, could re-
press—but not entirely abrogate—the complex assembly
(fig. 6). These considerations may account for the barely
present Rh50 glycoprotein and the severely reduced an-
tigen expression in the Rhmod membrane.
Rhmod syndrome is variable in terms of both antigen
expression and hematological manifestation (Chown et
al. 1972; McCuire Mallory et al. 1976; Nash and Sho-
jania 1987). This phenotypic diversity may attest to the
genetic complexity of regulator gene(s) (Tippett 1990).
Comparison of the present initiator defect with the mis-
sense change (Ser79rAsn) found in Rhmod(VL) (Cherif-
Zahar et al. 1996) indicates that differences in the degree
of penetrance depend on the location and nature of the
respective mutations. Although our results point to
“leaky” translation as a form of incomplete penetrance,
further studies will be required in order to derive a com-
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Figure 6 Model for the Rhmod phenotype caused by an incom-
pletely penetrated initiator mutation in the RHAG gene. In the Rhmod
proband (i.e., SM), the two copies of RHAG contain the same GrT
transversion in the ATG initiation codon (circled “T”) and are denoted
by horizontal unblackened boxes; her RH locus harbors structurally
normal D, Ce, and ce genes that are actively expressed. As shown, the
translation-initiator mutation alters neither gene transcription nor
mRNA splicing; however, it leads to alternative translation initiation,
by selective use of the downstream cryptic initiation-signal sequences,
thus producing truncated Rh50 proteins with different N-terminal se-
quences, which are denoted by notches. Such products are aberrant
in structure andmay directly affect their contact with theRh30protein,
via their N-terminal domains. They may also be defective in other
posttranslational events, such as membrane insertion and cellular
transport. These potential changes could largely decrease the formation
of a stable Rh complex in the plasma membrane, although the RH
locus itself harbors no mutation.
plete picture for Rhmod syndrome and to exclude the
involvement of a second “modifier” gene in other cases.
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